Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on Electroacupuncture Combined With Olanzapine-contained Four-drug Antiemetic Therapy for the Prevention of Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer (ECO Study)

NCT06200168 is registered in ClinicalTrials.gov with Jiuda Zhao as lead sponsor.

NCT NCT06200168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06200168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on Electroacupuncture Combined With Olanzapine-contained Four-drug Antiemetic Therapy for the Prevention of Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer (ECO Study)
Lead sponsor
Jiuda Zhao
Phase
Phase 3
Overall status
Recruiting
Start date
January 16, 2024
Completion date
December 31, 2026
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electroacupuncture, nausea and vomiting, olanzapine-contained four-drug antiemetic